NCT05868135 Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
| NCT ID | NCT05868135 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Olavs Hospital |
| Condition | Depression Moderate |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2021-09-09 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2021-09-09 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational multicentre study is to address the effectiveness and cost-effectiveness of providing a therapist guided internet based cognitive behavioural therapy (ICBT) for common mental disorders in a routine healthcare setting. Main research questions is 1) What is the effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics in routine care? 2) What is the cost-effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics? 3) Who benefits from guided internet-delivered treatment? 4) What are the predictors of drop-out from guided internet based treatment? 5) To what extent does user experiences of guided internet based treatment influence adherence and effectiveness? Participants will receive up to nine guided ICBT sessions (modules) and answer questionnaires covering symptoms severity, health related quality of life, work and social ability, user satisfaction and medication. All questionnaires are part of the standard patient follow up routines in the four treatment locations participating in the study. Analytical approach is to compare locations/clinics and subgroups of patients.
Eligibility Criteria
Inclusion Criteria: Having moderate depression, panic disorder and social anxiety disorder as a primary disorder. Access to computer and internet. Exclusion Criteria: Having severe depression, suicidal impulses and thoughts, bipolar disorders, psychosis, substance abuse, unstable medication last month, severe reading or writing disabilities.
Contact & Investigator
Elin T Ulleberg, Master
PRINCIPAL INVESTIGATOR
St. Olavs Hospital
Frequently Asked Questions
Who can join the NCT05868135 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression Moderate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05868135 currently recruiting?
Yes, NCT05868135 is actively recruiting participants. Contact the research team at vidar.halsteinli@stolav.no for enrollment information.
Where is the NCT05868135 trial being conducted?
This trial is being conducted at Bergen, Norway, Lillehammer, Norway, Trondheim, Norway, Tønsberg, Norway.
Who is sponsoring the NCT05868135 clinical trial?
NCT05868135 is sponsored by St. Olavs Hospital. The principal investigator is Elin T Ulleberg, Master at St. Olavs Hospital. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.